Coulie Bernard

President and CEO, DirectorPLIANT THERAPEUTICS, INC. (PLRX) · full profile →Form 4 · filed Apr 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
0 non-derivative · 14 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 17, 2026Disposed to issuer(D)147K$00
Apr 17, 2026Grant(A)147K$0147K
Apr 17, 2026Disposed to issuer(D)327K$00
Apr 17, 2026Grant(A)327K$0327K
Apr 17, 2026Disposed to issuer(D)250K$00
Apr 17, 2026Grant(A)250K$0250K
Apr 17, 2026Disposed to issuer(D)440K$00
Apr 17, 2026Grant(A)440K$0440K
Apr 17, 2026Disposed to issuer(D)206K$00
Apr 17, 2026Grant(A)206K$0206K
Apr 17, 2026Disposed to issuer(D)256K$00
Apr 17, 2026Grant(A)256K$0256K
Apr 17, 2026Disposed to issuer(D)325K$00
Apr 17, 2026Grant(A)325K$0325K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001746473-26-000053) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.